Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-26 @ 4:05 AM
Study NCT ID:
NCT03468218
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-05
First Post:
2018-03-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-29
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-10
First Submit QC Date:
None
Study First Post Date:
2018-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-05
Results First Submit QC Date:
None
Results First Post Date:
2024-12-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-22
Last Update Post Date:
2025-02-05
Last Update Post Date Type:
ACTUAL